WINDSOR, CONN. (Jan. 28, 2021)– SCA Pharmaceuticals, LLC, announced details last week of their acquisition by The Vistria Group and Excellere. Continuing their strategic growth initiatives, SCA Pharma is announcing the appointment of Mr. Scott Luce as Chief Commercial Officer. …
WINDSOR, CONN. (Jan. 21, 2021) – SCA Pharmaceuticals, LLC (“SCA Pharma”), has entered into a definitive membership interest purchase agreement with The Vistria Group (“Vistria”) and Excellere Partners (“Excellere”). The Vistria Group and Excellere Partners have purchased all of the…
SCA Pharma is taking a look at how hospitals choose to supply their compounded drug products. Many choose to produce what they need internally – called insourcing – while others use a provider like us – outsourcing. This second blog…
SCA Pharma just wrapped up the Health Connect Partners (HCP) Hospital Pharmacy fall virtual conference, where we shared a new virtual tour of the SCA Pharma facilities. The tour highlights the steps throughout the product journey, from receiving materials to…
Hospitals often choose to insource drug compounding in order to save money on Pharmacy costs. The decision to insource is typically based on a number of factors including cost of raw materials and qualified personnel needed to compound the product.…
October is National Medicine Abuse Awareness Month, an annual effort by the Community Anti-Drug Coalitions of America to raise awareness of the dangers of prescription and over-the-counter medicine abuse. And SCA Pharma is partnering with hospital pharmacies to better control…
SCA Pharma has made it easy for customers to get products quickly on non-recurring orders, and this tutorial walks customers through the process. “Buy and Ship Now" offers an inventory of finished goods that can be available to ship within…
Our goal at SCA Pharma always is to provide high quality products, service and value to our customers. During the COVID-19 pandemic, that’s been more important than ever. Several front-line healthcare workers have written us recently to say we’re doing…